Met Life Investment Management, LLC Savara Inc Transaction History

Met Life Investment Management, LLC

  • $18.1 Billion
  • Q1 2025

A detailed history of Met Life Investment Management, LLC transactions in Savara Inc stock. As of the latest transaction made, Met Life Investment Management, LLC holds 52,102 shares of SVRA stock, worth $110,977. This represents 0.0% of its overall portfolio holdings.

Number of Shares
52,102
Previous 59,049 11.76%
Holding current value
$110,977
Previous $181,000 20.44%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025
SELL
$2.32 - $3.14 $16,117 - $21,813
-6,947 Reduced 11.76%
52,102 $144,000
Q4 2024

Feb 13, 2025
SELL
$2.94 - $4.07 $23,102 - $31,982
-7,858 Reduced 11.74%
59,049 $181,000
Q3 2024

Nov 13, 2024
BUY
$3.96 - $5.07 $58,936 - $75,456
14,883 Added 28.61%
66,907 $283,000
Q2 2024

Aug 13, 2024
BUY
$3.66 - $5.34 $44,699 - $65,217
12,213 Added 30.68%
52,024 $209,000
Q1 2024

May 14, 2024
BUY
$4.19 - $5.59 $166,808 - $222,543
39,811 New
39,811 $198,000
Q4 2023

Feb 14, 2024
BUY
$3.18 - $4.9 $25,672 - $39,557
8,073 Added 19.91%
48,616 $228,000
Q3 2023

May 09, 2024
BUY
$2.97 - $3.88 $120,412 - $157,306
40,543 New
40,543 $153,000
Q2 2023

Apr 29, 2024
BUY
$1.69 - $3.24 $68,517 - $131,359
40,543 New
40,543 $129,000
Q2 2023

Aug 10, 2023
BUY
$1.69 - $3.24 $68,517 - $131,359
40,543 New
40,543 $129,000
Q2 2019

Jul 12, 2023
BUY
$2.37 - $11.7 $37,209 - $183,690
15,700 New
15,700 $37.2 Million
Q2 2019

Aug 14, 2019
SELL
$2.37 - $11.7 $37,209 - $183,690
-15,700 Closed
0 $0
Q1 2019

Jul 13, 2023
BUY
$6.71 - $8.6 $105,347 - $135,020
15,700 New
15,700 $115,000
Q1 2019

Mar 22, 2023
SELL
$6.71 - $8.6 $30,483 - $39,069
-4,543 Reduced 22.44%
15,700 $115,000
Q1 2019

May 15, 2019
BUY
$6.71 - $8.6 $105,347 - $135,020
15,700 New
15,700 $116,000
Q4 2018

Feb 14, 2019
SELL
$6.27 - $10.92 $126,923 - $221,053
-20,243 Closed
0 $0
Q3 2018

Jul 13, 2023
BUY
$10.49 - $12.87 $136,863 - $167,914
13,047 New
13,047 $145,000
Q3 2018

Mar 22, 2023
BUY
$10.49 - $12.87 $212,349 - $260,527
20,243 New
20,243 $225,000
Q3 2018

Nov 14, 2018
BUY
$10.49 - $12.87 $75,486 - $92,612
7,196 Added 55.15%
20,243 $226,000
Q2 2018

Aug 15, 2018
BUY
$8.55 - $13.76 $111,551 - $179,526
13,047 New
13,047 $148,000

Others Institutions Holding SVRA

# of Institutions
142
Shares Held
162M
Call Options Held
54.8K
Put Options Held
4.1K
View Full List

About Savara Inc

SVRA Quotes by TradingView
  • Ticker SVRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 114,043,000
  • Market Cap $243M
  • Description
  • Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.
More about SVRA
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email